Combination chemotherapy in radically operated advanced ovarian cancer.
Petru
E
E
Department of Obstetrics and Gynecology, University of Graz, Austria.
Pickel
H
H
Lahousen
M
M
Boike
G
G
Heydarfadai
M
M
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000379:methods; D015993:Life Tables; D008197:Lymph Node Excision; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D010052:Ovariectomy / Q000379:methods; D011238:Prednimustine / Q000008:administration & dosage; D015996:Survival Rate
D015251:Epirubicin; D004317:Doxorubicin; D003520:Cyclophosphamide; D011238:Prednimustine; D016190:Carboplatin; D002945:Cisplatin